Business Context and Reporting Period
This Form 6-K filing by Redhill Biopharma Ltd. is dated June 10, 2021, for the month of June 2021. The document serves as a Notice of Annual General Meeting of Shareholders scheduled for July 26, 2021, in Tel Aviv, Israel. The filing incorporates the notice by reference into various Registration Statements on Forms S-8 and F-3.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document is a procedural notice regarding corporate governance and shareholder meetings rather than a financial results report. Shareholders are noted to have an opportunity to review financial statements for the fiscal year ended December 31, 2020, at the meeting, but those figures are not included in this text.
Material Changes
No material financial changes versus prior periods are reported in this filing. The document outlines proposed corporate actions to be voted upon at the Annual General Meeting, including:
- Appointment of Kesselman & Kesselman as auditors for 2021.
- Re-election of directors Ofer Tsimchi and Eric Swenden, and election of Alessandro Della Chà.
- Amendments to director terms of service, the Compensation Policy, and Letters of Exemption and Indemnification.
- Amendments to the Amended and Restated Award Plan (2010).
- Grants of options to purchase American Depository Shares (ADSs) to directors, Mr. Rick D. Scruggs, and Mr. Dror Ben-Asher.
- Approval of an annual bonus and salary increase for Chief Commercial Officer Rick D. Scruggs, along with amended employment terms for him and Ms. June Almenoff.
Guidance, Outlook, and Risks
The filing contains no financial guidance, market outlook, or discussion of specific business risks. Management commentary is limited to the Board of Directors' recommendation that shareholders vote "FOR" the proposals listed in the notice. The filing notes that the Company is currently unaware of any other matters that may be raised at the General Meeting.
Key Facts for Investor Verification
- Meeting Date: Annual General Meeting is scheduled for July 26, 2021, at 3:00 p.m. Israel time.
- Record Date: Shareholders of record as of June 17, 2021, are entitled to vote.
- Executive Compensation: Shareholders will vote on a salary increase and bonus for the Chief Commercial Officer and amended employment terms for key personnel.
- Equity Dilution: Multiple proposals involve granting new stock options to directors and executives, which may impact share count.
- Auditor Continuity: The current auditors are being reappointed for the 2021 fiscal year.